by Eric Christianson | Apr 19, 2026 | Respiratory Medication and Disease State Clinical Pearls
Beta-blockers have long been approached with caution in patients with asthma due to their potential to provoke bronchospasm and blunt the effects of rescue inhalers. This risk is largely driven by receptor selectivity. In this article, we will break down the best and...
by Eric Christianson | Jan 25, 2026 | Respiratory Case Studies
In this case study, we outline a likely case of propranolol-induced asthma. Mr. J.S. is a 62-year-old male with a past medical history significant for essential tremor, mild persistent asthma, hypertension, and hyperlipidemia. His asthma has been well controlled for...
by Eric Christianson | Nov 13, 2024 | Respiratory Medication and Disease State Clinical Pearls
Two tests are commonly used in asthma assessments to monitor symptom control and airflow and this blog post will discuss their use and how they determine appropriate treatment options. Important tests pharmacists should know include the Asthma Control Test and a Peak...
by Eric Christianson | Jan 21, 2024 | Respiratory Medication and Disease State Clinical Pearls
There are so many inhalers on the market for asthma and COPD. LABA, LAMA, and ICS products are getting so hard to keep track of! Honestly, it gets a little overwhelming at times to remember them all by brand name and what category and classification they fall into. My...
by Eric Christianson | Dec 6, 2023 | Respiratory Medication and Disease State Clinical Pearls
Patients who live with asthma or COPD often require the use of inhaler(s) to help manage symptoms of their disease. As healthcare professionals we must ensure that the medications these patients are receiving actually work. In this article, we provide a table on...
